Leukemia

Risk-Adapted Bendamustine and Rituximab: An Alternative for Older Individuals With CLL

By

Christina Bennett, MS

Publish Date September 18, 2020

Risk-adapted dosing of bendamustine and rituximab may be beneficial and tolerable for elderly patients with CLL, a retrospective study found.

Targeted Molecular Therapies for the Treatment of Chronic Lymphocytic Leukemia

By

Jessica Nye, PhD

Publish Date September 14, 2020

Researchers reviewed promising advances in therapy options for patients with CLL and the challenges associated with these new treatments.

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

Publish Date September 11, 2020

[Blood and Lymphatic Cancer: Targets and Therapy] Although this retrospective analysis determined that ibrutinib was not associated with higher mortality in older patients with CLL, it did find greater intolerance with an increased number of early deaths in elderly patients treated with ibrutinib.

Outcomes for Adolescents With Acute Lymphoblastic Leukemia

By

Vicki Moore, PhD

Publish Date September 9, 2020

Clinical trial results indicate that adolescent patients with acute lymphoblastic leukemia have poorer outcomes than younger patients do.

Oral AML Therapy Onureg Gets FDA Approval

By

Brian Park, PharmD

Publish Date September 4, 2020

The approval was based on data from the multicenter, randomized, double-blind, placebo-controlled, phase 3 QUAZAR study.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .